DTIP-WINDGRU a novel drug-target interaction prediction with wind-enhanced gated recurrent unit
Kavipriya Gananathan1, D Manjula2, Vijayan Sugumaran3,4
1School of Computer Science Engineering (SCOPE), Vellore Institute of Technology, Chennai, 600127, India. kavipriya.g@vit.ac.in.
BMC Bioinformatics
|July 20, 2025
Summary
This study introduces DTIP-WINDGRU, a novel computational intelligence model for predicting drug-target interactions (DTI). The model accurately identifies DTIs in both labeled and unlabeled samples, outperforming existing methods.
Area of Science:
- Computational intelligence
- Machine learning
- Drug discovery
Background:
- Drug-target interaction (DTI) identification is crucial for drug discovery but is time-consuming via lab tests.
- Computational intelligence (CI) offers essential automated prediction tools.
- Challenges include limited data, lack of negative samples, and complex existing models.
Purpose of the Study:
- To develop a novel DTI prediction model, DTIP-WINDGRU (Drug-Target Interaction Prediction with Wind-Enhanced GRU).
- To accurately determine DTIs in both labeled and unlabeled samples, surpassing traditional methods.
- To leverage advanced machine learning (ML) and deep learning (DL) for effective DTI prediction.
Main Methods:
- The DTIP-WINDGRU model incorporates pre-processing and class labeling.
- Drug-to-drug (D-D) and target-to-target (T-T) interactions initialize GRU model weights.
- Wind Driven Optimization (WDO) algorithm is used for optimal hyperparameter selection in the GRU model.
Main Results:
- The DTIP-WINDGRU model demonstrated effective DTI prediction capabilities.
- The model accurately identified interactions in both labeled and unlabeled datasets.
- Comparative analysis confirmed superior performance over existing DTI prediction techniques.
Conclusions:
- The DTIP-WINDGRU model offers a robust solution for DTI prediction.
- Extensive experimentation validated the model's efficacy across four datasets.
- The study highlights DTIP-WINDGRU's superior performance compared to current methods.
Keywords:
Deep learningDrug-target interactionGated recurrent unitPrediction modelWind driven optimizationMore Related Videos
Related Concept Videos
Drug-Receptor Interactions
6.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.0K
Quantitative Aspects of Drug-Receptor Interaction
1.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.2K
Protein-protein Interfaces
13.3K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.3K
Drug-Receptor Interaction: Agonist
2.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.8K


